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Our knowledge of the destructive events that regu-
late axonal degeneration is rudimentary. Here, we
examine the role of caspases and their endogenous
inhibitor, the X-linked inhibitor of apoptosis protein
(XIAP), in axonal degeneration of dorsal root ganglion
(DRG) axons. We show that caspase-3, caspase-6,
and caspase-9 are present in axons and are cleaved
upon nerve growth factor (NGF) withdrawal. We
observed that caspase-3 activity is high in NGF-with-
drawn axons and thatCASP3/ axons are protected
from degeneration. XIAP/ DRG sensory neurons
degenerate more rapidly and contain more active
caspase-3 than their wild-type counterparts, indi-
cating that axonal caspases are normally regulated
by XIAP. Importantly, axonal XIAP levels drop
sharply after NGFwithdrawal; if XIAP levels aremain-
tained by overexpression, axonal caspase-3 activa-
tion and axonal degeneration are suppressed.
Finally, we show that XIAP/ embryos have stunted
dermal innervation. We propose that XIAP-mediated
caspase inhibition plays an important role in regu-
lating morphogenic events that shape the nervous
system during development.INTRODUCTION
Axonal degeneration is an important developmental event that
distinguishes neurons that successfully compete for activity-
or target-derived trophic factors from those that do not (Saxena
and Caroni, 2007). The loss of neuronal termini and axons can
affect a single neuronal subdomain or it can be the first step
in the cascade that culminates in the apoptosis of neuronal
cell bodies during development and in neurodegenerative dis-
ease. The precise mechanisms and regulatory events that
impinge on axonal degeneration are not completely understood;
however, recent findings show that axonal loss does not reflect
unregulated withering, but instead occurs through tightlycontrolled destruction of the axonal subcellular domain (Wang
et al., 2012).
Caspases were ruled out as major effectors in neurite degen-
eration several years ago (Finn et al., 2000; Whitmore et al.,
2003), but recent findings suggest that these proteases may in
fact play key roles. This was first demonstrated in Drosophila
melanogaster for class IV dendritic arborization sensory neurons,
which elaborate dendritic arbors in the pupal stage and subse-
quently are pruned during larval metamorphosis (Truman,
1990). The fly caspase DRONC becomes selectively active in
these arbors during morphogenesis and drives the pruning pro-
cess (Kuo et al., 2006; Williams et al., 2006). The activation state
of DRONC within these dendrites is controlled by the Drosophila
inhibitor of apoptosis protein 1 (DIAP1), a member of the IAP
family (Meier et al., 2000; Quinn et al., 2000). In the nonmorpho-
genic phases, DIAP1 represses DRONC, but during morphogen-
esis DIAP1-mediated caspase inhibition is relieved, allowing
DRONC to actively cleave substrates and drive neurite loss
(Kuo et al., 2006).
A role for caspases in neurite degeneration seems to be
phylogenetically conserved, since recent studies from several
groups suggested that caspase-6 plays a key role in the degen-
eration of dorsal root ganglion (DRG) axons mediated by nerve
growth factor (NGF) withdrawal (Schoenmann et al., 2010; Vohra
et al., 2010). The involvement of caspase-6 in axonal degenera-
tion was found to be highly specific, and other caspases,
including caspase-3, did not appear to play a significant role.
However, more recent work has suggested that caspase-6
may have a subsidiary role, and that caspase-3 and caspase-9
play dominant roles in developmental degeneration (Simon
et al., 2012).
X-linked IAP (XIAP), the mammalian equivalent of DIAP1, is the
only mammalian IAP family member that directly inhibits
caspases (Eckelman et al., 2006). XIAP does not block caspase
activation, but rather inhibits target caspases after they are
activated. This postactivation inhibition occurs because XIAP
binds the neo-epitope that is exposed when caspases are
activated by cleavage. The cleavage epitopes in caspase-3,
caspase-7, and caspase-9 are tightly bound by XIAP, but XIAP
does not bind the corresponding epitope in caspase-6 and
as a result does not block caspase-6 activity (Salvesen and
Duckett, 2002).Cell Reports 4, 751–763, August 29, 2013 ª2013 The Authors 751
Figure 1. Caspase-3 and Caspase-9 Are Robustly Activated in Degenerating Axons
(A) Twiss cultures allow axons to be isolated for biochemical analyses.
(B) Optical planes obtained by confocal microscopy show that DAPI-positive neuronal nuclei remain on top of the filter, whereas axons grow on the top and
bottom. Scale bar, 200 mm.
(C) Immunoblots of lysates collected from filter tops versus bottoms demonstrate that histone H3, a nuclear marker, is confined to the filter tops.
(D) Caspase cleavage profile in NGF-deprived DRG cell bodies and axons.
(E) An in situ caspase-trapping assay using biotin-VAD shows that active caspase-3 is abundant in axons subjected to NGF withdrawal, but is not detectable in
axons maintained in NGF.
(F) Cleaved and active caspase-3 and caspase-6 were detected in samples from cell bodies 12 hr after neurons were subjected to NGF withdrawal.In this study, we tested the hypothesis that the caspase-IAP
link that regulates neurite degeneration in flies is phylogenetically
conserved and functions in mammals. We found that caspase-3
and caspase-9 are robustly cleaved in NGF-deprived mouse
DRG axons, and established that their activity plays a crucial
role in driving axonal degeneration. XIAP functions as a signifi-
cant regulator of caspase activity in this setting, as axons derived
from XIAP/ DRG sensory neurons show increased caspase-3
activity and accelerated degeneration when withdrawn from
NGF. We also found that XIAP levels are dramatically reduced
in DRG axons subjected to NGF withdrawal, raising the possibil-
ity that XIAP loss or inhibition may be a prerequisite for axonal
degeneration. Consistent with this, we found that sustaining
XIAP levels in degenerating axons sharply reduces caspase-3
activation and axonal degeneration. In contrast, XIAP and its
target caspases are not required for axonal degeneration that
occurs after axotomy. Taken together, these results show that
caspase-3 and caspase-9 play crucial roles in axonal degenera-752 Cell Reports 4, 751–763, August 29, 2013 ª2013 The Authorstion, that their activities are regulated by XIAP, and that a
phylogenetically conserved caspase-IAP regulatory loop plays
a crucial role in regulating morphogenic events in the nervous
system.
RESULTS
Caspase-3 and Caspase-9 Are Robustly Activated in
Degenerating Axons
To examine the role of caspases in axonal degeneration, we
established NGF-dependent dorsal root sensory neuron
explants using the Twiss method (Zheng et al., 2001). In this
method, neuronal cell bodies remain isolated atop a porous filter
while axons pass through the filter and extend along the bottom
surface. Pure axons (free of glia and neuronal cell body contam-
inants) that are present on the bottom surface of the filter can be
examined by immunocytochemical techniques or isolated for
biochemical analyses (Figures 1A–1C). NGF supports robust
Figure 2. Caspase-3 Cleavage Is Develop-
mentally Regulated
(A) DRG explants derived from E13.5 embryos
extend longer axons in response to NGF than ex-
plants from E17.5 embryos. Explants in this and
other figures were stained with an anti-bIII-tubulin
antibody to visualize axons. Scale bar, 400 mm.
(B and C) Representative micrographs (B) and
quantification (C) of axons of DRG explants derived
from E13.5 or E17.5 embryos maintained in NGF or
after 24 hr NGF withdrawal. Data are presented as
mean + SEM. Scale bar, 200 mm.
(D) Axonal samples derived from E13.5 or E17.5
explants maintained in NGF or deprived of NGF for
12 hr were analyzed for caspase-3 cleavage by
immunoblot.
(F) Proforms and cleaved forms of axonal
caspase-3 from E13.5 DRGs plated on substrates
lacking or containing collagen were assessed by
immunoblot.
(E) Axonal morphology of E13.5 DRG explants
plated on substrates lacking or containing collagen
were assessed 12 hr after NGF withdrawal. Scale
bar, 200 mm.survival and axonal growth of embryonic day 13.5 (E13.5) DRG
sensory neurons in this setting, but when they are deprived of
NGF, axons maintained in Twiss cultures undergo rapid degen-
eration. We used this culture system to analyze the caspase
cleavage profile of axons that were maintained in NGF or were
NGF deprived. Consistent with recent findings, we found that
NGF deprivation induced caspase-6 cleavage (Nikolaev et al.,
2009; Schoenmann et al., 2010; Vohra et al., 2010). We also
observed that NGF withdrawal caused robust caspase-3
cleavage and a dramatic loss of pro-caspase-9 (Figure 1D).
Caspase cleavage does not invariably correlate with caspase
activity. The protease activity that is present in vivo will depend
on posttranslational modifications to the caspase and on levels
of endogenous inhibitors that block caspase action. Also,
biochemical analyses can produce artifactual results since cell
lysis can disrupt endogenous interactions and activate zymo-
gens that promote caspase cleavage. Therefore, we modified
the caspase-trapping assay (Tu et al., 2006) to examine the
levels of activated caspases present within NGF-deprived
axons. Neurons maintained in the Twiss format were deprived
of NGF for 12 hr and then incubated for 90 min with biotin-
VAD-fmk (bVAD), a cell-permeable compound that irreversiblyCell Reports 4, 751–76binds active caspases within intact cells.
Streptavidin pull-downs were performed
on lysates of purified axons exposed to
bVAD, and immunoblots were used to
identify the bVAD-caspase conjugates
that had formed. This approach revealed
that active caspase-3 was abundant in
axons subjected to NGF withdrawal, but
was not detectable in axons maintained
in NGF (Figure 1E). Activated caspase-6
was most likely below our detection limit
in NGF-deprived axons (data not shown),but active caspase-3 and caspase-6 were present in cell bodies
12 hr after neurons were subjected to NGF withdrawal (Fig-
ure 1F). Interestingly, the small amount of cleaved caspase-3
that was present in neurons maintained in NGF appeared to be
inactive. We conclude that NGF withdrawal leads to a massive
increase in cleaved and active caspase-3 within DRG sensory
axons.
Previous attempts to examine caspase-3 activation in axons
after NGF withdrawal have produced conflicting results, and
we were interested in determining whether these discrepancies
reflect biological or procedural variables. Some experiments
examined DRG axons derived from embryos at later stages of
development than those used here, or from embryos maintained
in vitro for prolonged periods (Nikolaev et al., 2009). We
compared axonal degeneration and caspase activation in
DRGs derived from E13.5 versus E17.5 embryos and found
that outgrowth from the E13.5 DRGs was considerably more
robust and degeneration of axons from the E17.5 DRGs was
less severe (Figures 2A–2C). This correlated with changes in
caspase activity: axons grown from E13.5 explants displayed
considerably higher levels of cleaved caspase-3 upon NGF with-
drawal than those derived from E17.5 explants (Figure 2D).3, August 29, 2013 ª2013 The Authors 753
Therefore, we conclude that deprivation-induced caspase-3
cleavage is developmentally regulated.
Because axonal degeneration has beenmeasured on a variety
of substrates (Nikolaev et al., 2009; Schoenmann et al., 2010;
Vohra et al., 2010), we also asked whether plating factors had
an impact on axonal stability or caspase cleavage. Figure 2E
shows that axons grown on PDL+laminin+collagen display low
levels of cleaved caspase-3 when they are maintained in NGF
and high levels when they are deprived of this factor. In contrast,
axons grown on PDL+laminin without collagen have high levels
of cleaved caspase-3, even in the presence of NGF, which
makes it difficult to observe an increase in caspase cleavage
upon NGF withdrawal. Interestingly, axons maintained on
PDL+laminin very rapidly degenerate when they are withdrawn
from NGF, perhaps because the high levels of cleaved
caspase-3 that are present even when NGF is provided primes
them for rapid degeneration upon NGF withdrawal (Figure 2F).
Unless otherwise specified, subsequent experiments were per-
formed using the PDL+laminin+collagen substrate.
A Caspase-9-to-Caspase-3 Cascade Is Required for
Normal Axonal Degeneration
The robust caspase cleavage observed in axons suggests a
central role for executioner caspases in axonal degeneration.
To confirm this, we first examined the effect of chemical inhibi-
tion of caspase-3 and caspase-6 on axonal breakdown induced
by NGF withdrawal. Figures 3A and 3B show that the caspase-3
inhibitor significantly reduced degeneration, whereas the
caspase-6 inhibitor had only a minor effect (Figures 3A and 3B).
To confirm this, we compared axonal degeneration in DRGs
prepared from E13.5CASP3+/+,CASP3+/, andCASP3/ litter-
mates. Figure 3C shows the expected changes in caspase-3
protein expression across genotypes and confirms that basal
levels of caspase-9, caspase-6, and XIAP remain unchanged
regardless of caspase-3 expression. Figures 3D and 3E show
thatCASP3+/+ andCASP3+/ DRGs show normal axonal degen-
eration upon NGF withdrawal for 24 hr, whereas CASP3/
DRGs were completely protected from NGF-dependent axonal
degeneration.
Given these results, it seemed odd that axonal degeneration
induced by NGF withdrawal in wild-type axons was only partially
blocked by the caspase-3 or caspase-6 inhibitors. A possible
explanation for this is that the cellular levels of the caspase inhib-
itors that can be achieved are insufficient to block the abundant
cleaved caspase-3 that is generated upon NGF deprivation.
Consistent with this, we found that zVAD, a pan-caspase inhib-
itor, rescued only 30% of NGF-deprived wild-type axons, but
rescued 85% of CASP3+/ axons (Figure 3F).
In many settings, activation of caspase-9 precedes and is
required for caspase-3 activation (Vaux and Silke, 2005). Consis-
tent with this, we found that axonal caspase-3 and caspase-6
cleavage was completely blocked when sensory neurons were
pretreated with a caspase-9 inhibitor (Figure 3G). Interestingly,
the caspase-6 inhibitor had no effect on caspase-3 or
caspase-6 cleavage, but the caspase-3 inhibitor increased the
levels of both, suggesting that under normal circumstances,
caspase-3 targets itself and caspase-6 for destruction. To deter-
mine whether caspase-3 is required to process caspase-6 to its754 Cell Reports 4, 751–763, August 29, 2013 ª2013 The Authorsactivated form within degenerating axons, we compared axonal
DRGs samples prepared from E13.5 CASP3+/ and CASP3/
littermates. Figure 3H shows that NGF-deprived CASP3+/
axons generate cleaved caspase-6, whereas CASP3/ axons
fail to do so, indicating that caspase-3 activity is required for cas-
pase-6 activation in NGF-deprived DRG axons.
We conclude that caspase-9 is an important initiator caspase
in this pathway, that caspase-3 plays a crucial role in driving
axonal degeneration, and that abundant caspase-3 (consider-
ably more than is actually required to drive degeneration) is
generated upon NGF deprivation.
XIAP Normally Restrains Axonal Caspase-3 Activity
XIAP functions as a potent inhibitor of caspase-3 and caspase-9
in vitro, but it is not knownwhether it performs this function under
physiological circumstances. To address this issue, we asked
whether XIAP/ DRG axons undergo more rapid degeneration
than their wild-type counterparts. Consistent with this notion,
we found that degeneration was significantly increased in
XIAP/ neurons deprived of NGF for 12 hr (Figures 4A and
4B). We then asked whether the increased degeneration rate in
DRG axons derived from XIAP/ mice is correlated with
changes in caspase cleavage and activation. Figure 4C shows
that cleaved caspase-3 levels are slightly increased in XIAP/
axons maintained in NGF and are strongly elevated in XIAP/
axons deprived of NGF for 6 hr. Using the caspase trapping
technique, we found that the enhanced cleavage correlates
with a significant increase in caspase-3 activity in XIAP/
axons, both in the presence of NGF and after its withdrawal (Fig-
ure 4D). We conclude that XIAP normally functions to restrain
caspase-3 activity within degenerating axons.
XIAP binds the large subunit of caspase-3 via the epitope that
is generatedwhen the procaspase is cleaved. Because this is the
same epitope detected by cleavage-specific caspase anti-
bodies, we asked whether XIAP has an impact on the immuno-
cytochemical detection of cleaved caspase-3. To address this,
we first confirmed the specificity of the cleavage-specific
caspase-3 antibody by performing immunostains of NGF-
deprived DRG explants derived from E13.5 CASP3+/+ or
CASP3/ littermates. Figure 5A shows that neuronal cell bodies
within the wild-type DRGs explants display prominent cleaved
caspase-3 immunoreactivity, whereas axons derived from these
same ganglia are not immunostained. Cell-body staining for
cleaved caspase-3 is absent in CASP3/ DRG explants sub-
jected to an identical treatment, indicating that this antibody
does indeed target cleaved caspase-3 (Figure 5A), but that anti-
gen can only be detected in cell bodies. We then asked whether
immunocytochemical detection of cleaved caspase-3 differed in
NGF-deprived XIAP/ neurons. Figures 5B and 5C show that
wild-type DRG axons deprived of NGF display little cleaved
caspase-3 immunostaining, whereas XIAP/ axons show abun-
dant staining for this antigen when they are withdrawn fromNGF.
XIAP Must Be Removed for Degeneration to Proceed
Because XIAP is a potent caspase inhibitor, we hypothesized
that it has to be removed or antagonized for caspase-dependent
degeneration to proceed. To determine whether XIAP is downre-
gulated in axons undergoing degeneration, we examined XIAP
Figure 3. A Caspase-9 to Caspase-3 Cascade Is Essential for Axonal Degeneration
(A and B) Representative micrographs (A) and quantification (B) of axons from DRG explants that were maintained in NGF or deprived of NGF for 24 hr, in the
absence or presence of indicated caspase inhibitors. Data are presented as mean + SEM. Scale bar, 200 mm.
(C) Levels of caspase-3, caspase-6, caspase-9, and XIAP were assessed by immunoblot in the indicated caspase-3 genotypes.
(D and E) Representative micrographs (D) and quantification (E) of axons from E13.5 wild-type and CASP3/ DRG explants maintained on NGF or deprived of
NGF for 24 hr. Data are presented as mean + SEM. Scale bar, 200 mm.
(F) Axons from wild-type and caspase-3 heterozygous DRG explants maintained on NGF or deprived of NGF for 24 hr in the absence or presence of a
pan-caspase inhibitor. Data are presented as mean + SEM.
(G) Neurons were deprived of NGF and incubated with indicated caspase inhibitors for 12 hr. Axonal lysates were prepared and levels of caspase-3 and cleaved
caspase-6 were established by immunoblot.
(H) Axons from E13.5 wild-type and CASP3/ DRG explants were maintained on NGF or deprived of NGF for 15 hr. Axonal lysates were prepared and levels of
caspase-3 and caspase-6 were established by immunoblot.protein levels in sensory axons deprived of NGF for periods
ranging from 6 to 24 hr. Figure 6A shows that, as predicted,
XIAP levels decline significantly throughout this time period,
with the protein becoming almost undetectable after 24 hr of
deprivation.
To test whether this XIAP loss is a prerequisite for axonal
degeneration, we generated a recombinant lentivirus that over-expresses XIAP and used it to elevate XIAP levels in dissociated
DRG sensory neurons maintained in Twiss cultures. Figure 6B
shows that infected neurons maintain axonal XIAP expression
even after NGF withdrawal, and reveals that XIAP overex-
pression strongly suppresses the accumulation of cleaved
caspase-3 in axons deprived of NGF. Figures 6C and 6D show
that sustained XIAP expression significantly enhances axonalCell Reports 4, 751–763, August 29, 2013 ª2013 The Authors 755
Figure 4. XIAP Restrains Axonal Caspase-3
Activity
(A and B) Representative micrographs (A) and quan-
tification (B) of axon maintenance in wild-type or
XIAP/DRGs subjected to NGF withdrawal. Data are
presented as mean + SEM. Scale bar, 200 mm.
(C and D) Wild-type and XIAP/DRGs were deprived
of NGF for 6 hr and axonal samples were then
analyzed for levels of cleaved (C) or active (D)
caspase-3 levels by the biotin-VAD-fmk trapping
assay and immunoblotting.integrity in neurons deprived of NGF.We conclude that XIAP loss
is a prerequisite for caspase-3 activity and axonal degeneration
in NGF-deprived neurons.
We then asked whether transcriptional or posttranslational
mechanisms contribute to the decrease in XIAP levels that
are observed after NGF withdrawal. Figure 6E shows that
messenger RNA (mRNA) levels remain stable after NGF depriva-
tion, whereas the decrease in XIAP protein can be largely
prevented by either one of two chemically distinct proteosomal
inhibitors: epoxomicin and bortezomib (Figure 6F). Some studies
have shown that caspase-3 can cleave XIAP (Deveraux et al.,
1999; Ho¨rnle et al., 2011), so we also asked whether XIAP loss
still occurred in axons lacking caspase-3. Figure 6G shows
that the loss of XIAP protein was not blocked in CASP3/
axons, indicating that the ubiquitin-proteasome system is the
primary degradative pathway used to reduce XIAP levels after
NGF deprivation.
Caspase-3 and XIAP Do Not Alter Axonal Degeneration
Induced by Axotomy
The axonal degeneration that occurs during development is
distinct from that which occurs after axotomy. To determine
whether caspase-3 or XIAP regulate axotomy-induced axonal
degeneration, we examined axotomy in vitro using DRG ex-
plants that had been established in Twiss cultures maintained
with NGF for 60 hr. We then mechanically removed the explants
containing the cell bodies by scraping the upper surface of the
filter, thereby allowing axotomy-induced degeneration to occur
in the axons remaining on the filter’s bottom surface. We char-
acterized changes by quantifying the loss of intact axons (green756 Cell Reports 4, 751–763, August 29, 2013 ª2013 The Authorsin Figure 7A) and quantifying increases in
axonal debris (superimposed in red in Fig-
ure 7A). In this setup, degeneration
occurred very rapidly and was essentially
complete by 6 hr (see Figure 7E). Previous
studies have shown that axotomy-induced
degeneration can be largely blocked by
nicotinamide adenine dinucleotide (NAD)
and significantly reduced by N-acetyl-
leucyl-leucyl-norleucinal (ALLN), a calpain
inhibitor (Araki et al., 2004; George et al.,
1995), and these effects were replicated in
the assay used here (Figures 7A–7C). Inter-
estingly, the caspase-3 inhibitor did not
have a significant effect on axonal fragmen-tation, but both it and the calpain inhibitor increased the
accumulation of postfragmentation debris (Figure 7C). Our inter-
pretation of this result is that caspase-3 may play a role in
axonal destruction, but only after the initial axonal fragmentation
has taken place. Given this, it is not surprising that wild-type
and XIAP/ neurons show indistinguishable degeneration rates
after axotomy (Figures 7D and 7E). Therefore, it seems that the
caspase-3/XIAP regulatory loop is important for regulating
morphogenetic changes under physiological circumstances,
but is dispensable for the axonal degeneration that occurs
after acute injury.
XIAP/Mice ShowDecreased Skin Sensory Innervation
During development, sensory neurons project to the dermis and
compete for limiting amounts of NGF, and the subset of
neurons that fail in this competition undergo degeneration.
Since loss of XIAP results in increased axonal caspase-3 activ-
ity, we reasoned that embryos that lack XIAP may have deficits
in sensory innervation patterns. To test this, we examined nerve
endings in forelimb skin of E15.5 XIAP/ embryos and wild-
type littermates. Figures 8A and 8B show that XIAP/ embryos
display almost 35% less skin innervation compared with wild-
type littermates. One possible explanation for this is that
E15.5 XIAP/ animals have fewer DRG sensory neurons than
their wild-type counterparts. However, stereological counts
showed that XIAP+/+ and XIAP/ animals had the same
number of DRG sensory neurons (Figure 8C). We conclude
that XIAP-mediated caspase regulation shapes sensory axon
innervation of target fields under normal physiological circum-
stances in vivo.
Figure 5. XIAP Depletion Enhances
Immunocytochemical Detection of Cleaved
Caspase-3
(A) Representative micrographs of explants from
NGF-deprived wild-type or CASP3/ explants
stained with antibodies against bIII-tubulin or
cleaved caspase-3. Nuclear DNA was detected
using DAPI. Scale bar, 200 mm.
(B and C) Representative micrographs (B) and
quantification (C) of explants from wild-type or
XIAP/ explants maintained in NGF or deprived of
NGF for 12 hr, and stained with antibodies against
bIII-tubulin or cleaved caspase-3. Data are pre-
sented as mean + SEM. Scale bar, 100 mm.DISCUSSION
Axonal and dendrite degeneration and pruning are physiological
processes that are essential for appropriate development of the
nervous system. Recent studies indicate that caspases are
essential elements in degenerative events of nervous systems
across phylogeny. It is likely that signaling events that activate
and limit caspase activity are similarly conserved, and here we
tested the notion that a caspase-IAP regulatory loop regulates
axonal degeneration in mammals. We focused on XIAP, one of
eight IAP family members present in mammals, because
biochemical and structural studies have shown that XIAP is the
only IAP family member that directly inhibits caspases (Eckel-
man et al., 2006). We show that XIAP normally functions to
reduce caspase activity in axons and that XIAP removal is
a prerequisite for caspase-dependent axonal degeneration.
Although a role for caspases in developmental degeneration
and pruning is well established in Drosophila, the idea that
caspase activation plays a role in axonal degeneration in
mammalian systems has been controversial. Early studies using
pharmacological approaches indicated that caspase-3 did not
play a significant role in sensory axon degeneration (Finn et al.,
2000; Whitmore et al., 2003), but was involved in olfactory
neuron degeneration during development and after target field
removal (Cowan and Roskams, 2004; Cowan et al., 2001).
More recent studies demonstrated that axons lacking Bax or
overexpressing Bcl-Xl were protected from degeneration (Niko-
laev et al., 2009; Schoenmann et al., 2010; Vohra et al., 2010), but
data on the specific roles of potential downstream caspase have
been mixed. Using cleavage-specific caspase antibodies and
pharmacological caspase inhibitors, Nikolaev et al. (2009)
reported that cleaved caspase-6, but not cleaved caspase-3,Cell Reports 4, 751–76was present in degenerating DRG axons.
Schoenmann et al. (2010) also ruled out
a significant role of caspase-3 in axonal
degeneration, but this was because their
studies indicated that axons contain high
levels of cleaved caspase-3 even before
NGF withdrawal.
We examined the caspase activation
profile in NGF-deprived sensory axons
that were separated from neuron cell
bodies and from supporting glia. Usingthis approach, we found that caspase-9 was rapidly processed
upon NGF withdrawal, and that this in turn led to the
cleavage of caspase-3 and caspase-6. Furthermore, using a
caspase-trapping assay, we demonstrated that the abundant
cleaved caspase-3 that accumulates within degenerating axons
is fully active. The disparate results reported to date may reflect
differences among the experimental systems employed. Some
studies have used DRG neurons derived from E17.5 mice, but
we found that these older neurons show less exuberant
outgrowth and a dramatic reduction in cleaved caspase-3
upon NGF deprivation compared with their E13.5 counterparts.
A variety of substrates have been used to maintain DRG neurons
for this type of study, and we found that the caspase-3
activation profile is highly sensitive to plating conditions. In our
culture system, substrates lacking collagen result in higher
basal caspase-3 cleavage and a corresponding reduction in
caspase-3 activation upon NGF withdrawal, which may explain
the high levels of cleaved caspase-3 observed by Schoenmann
and colleagues (2010) even in the presence of NGF.
The abundance of cleaved and active caspase-3 in axons sug-
gested that this executioner caspase is likely to play an important
role in axonal degeneration, and our pharmacological and
genetic studies support this contention. We found that cleavage
of capase-3 and caspase-6 could be completely blocked by
zLEHD-fmk, a caspase-9 inhibitor, and that zDEVD-fmk, a
caspase-3 inhibitor, conferred a significant but incomplete
rescue of sensory axon degeneration. In this assay system, the
caspase-6 inhibitor zVEID-fmk provided only mild protection.
Finally, we confirmed the involvement of caspase-3 by taking a
genetic approach. The complete protection observed in the
CASP3/ axons was striking and clearly demonstrates a role
for caspase-3 in axonal degeneration. Caspase inhibitors3, August 29, 2013 ª2013 The Authors 757
Figure 6. XIAP Removal Precedes Axonal Degeneration
(A) DRG axons were deprived of NGF for the indicated times and analyzed for levels of XIAP and for intact and cleaved caspase-3.
(B) Dissociated DRG neurons were infected with control lentivirus or lentivirus expressing XIAP, and maintained in NGF or deprived of NGF for 12 hr. Isolated
axons were analyzed for levels of cleaved caspase-3 by immunoblot.
(C and D) Representative micrographs (C) and quantification (D) of axon maintenance of dissociated DRG neurons that were infected with control lentivirus or
lentivirus expressing XIAP and then maintained in NGF or deprived of NGF for 24 hr. Data are presented as mean + SEM. Scale bar, 200 mm.
(E) mRNA levels of XIAP within DRGs subjected to NGF withdrawal were assessed by quantitative RT-PCR. PCR reactions shown in the first two lanes received
half and twice, respectively, asmuch complementary DNAof the fourth lane, to control for linearity of the PCR conditions. The last two lanes showRT-PCR of RNA
derived from wild-type or XIAP/ embryonic fibroblasts.
(F) DRGsweremaintained in NGF or deprived of NGF for 12 hr and then exposed to epoxomicin or bortezomib for 3 hr. Axonal samples were analyzed for levels of
XIAP and ubiquitin by immunoblot.
(G) Axons from E13.5 wild-type and CASP3/ DRG explants were maintained on NGF or deprived of NGF for 15 hr. Axonal lysates were prepared and levels of
pro-caspase-3 and XIAP were established by immunoblot.
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Figure 7. XIAP Deletion Does Not Alter Axotomy-Induced Degeneration
(A) Representative micrographs of intact or axotomized axons in the presence or absence of the indicated drugs. In the top row, continuous normal axons are
shown in green, and fragmented axons and debris are shown in red (superimposed on the green channel). Middle and bottom rows show themasks created from
the original pictures for intact (middle row) or fragmented (bottom row) axons. Scale bar = 200 mm.
(B and C) Quantification of normal (B) and fragmented (C) axons from experiments as shown in (A). Data are presented as mean + SEM.
(D and E) Representative micrographs (D) and quantification (E) of axon maintenance in wild-type or XIAP/ DRG axons at different time points after axotomy.
Data are presented as mean + SEM. Scale bar, 200 mm.provided modest protection from NGF-withdrawal-induced
deprivation in wild-type neurons, but almost completely rescued
CASP3+/ axons. This suggests that the abundant activated
caspase-3 produced is likely to exceed the inhibitory capacity
of chemical caspase inhibitors. In this scenario, the lower levels
of activated caspase-3 generated in CASP3+/ axons would fall
below the threshold necessary to achieve a complete chemical
blockade, resulting in a complete block of degeneration. This
may explain why previous attempts to block axonal degenera-
tion using chemical inhibitors have produced variable results,
and raises a cautionary note about the use of these reagents in
other biological contexts. In contrast to its role in developmentaldegeneration, caspase-3 does not appear to play a significant
role in mediating axonal fragmentation after axotomy.
Previous studies have shown that extracellular calcium entry
and activation of calpains are necessary for axotomy-induced
degeneration and that NAD+ can preserve axons after injury
(Wang et al., 2012). Using an in vitro axotomy paradigm that
we established in the Twiss system, axonal degeneration was
reduced by calpain inhibition and completely blocked by
NAD+. The initial fragmentation of axons that occurred after
axotomy was not reduced in CASP3/ axons; interestingly,
however, postfragmentation debris clearing was reduced in the
axons lacking this caspase. Thus, caspase-3 activation doesCell Reports 4, 751–763, August 29, 2013 ª2013 The Authors 759
Figure 8. XIAP/ Embryos Display Decreased Skin Innervation In Vivo
(A) Representative sections of the forelimb skin of wild-type and XIAP/ E15.5 embryos stained for bIII-tubulin and the nuclear marker DAPI. Scale bar, 50 mm.
(B) Quantification of bIII-tubulin fibers reaching the dermis-epidermis border of the experiment shown in (A). Data are presented as mean + SEM.
(C) Number of sensory neurons within DRGs (L1–L3) in wild-type and XIAP/ E15.5 embryos. Data are presented as mean + SEM.not initiate axonal loss after axotomy, but the caspasemay play a
role in later stages of axonal clearing.
The study of Nikolaev et al. (2009) was intriguing because it
indicated that caspase-6 was a crucial driver for axonal degen-
eration and specifically ruled out a role for caspase-3 in this
process. Very recently, the same group (Simon et al., 2012) reex-
amined these issues and found that a caspase-9 to caspase-3
cascade is crucial for axonal degeneration induced by NGFwith-
drawal, with caspase-6 activation playing a subsidiary role. Our
data agree with this more recent work in several ways. Most
significantly, both studies find that CASP3/ axons are
completely protected from NGF-withdrawal-induced axonal
degeneration, but are not protected from axotomy-induced
degeneration. Furthermore, both studies find that caspase inhib-
itors are much more effective in a CASP3+/ background than in
a CASP3+/+ background. Therefore, it seems likely that caspase
activity outstripped the action of the inhibitors used in early
studies on this topic (Finn et al., 2000; Whitmore et al., 2003),
leading to erroneous conclusions about the role of caspase-3
in this process.
Simon et al. (2012) reported that XIAP levels remained con-
stant after NGF withdrawal, a finding that is at odds with the pre-
cipitous drop in XIAP levels we found in isolated axons, aswell as
with earlier studies examining XIAP levels in NGF-deprived sym-
pathetic neurons and DRG sensory neurons (Potts et al., 2003;
Schoenmann et al., 2010). Simon et al. (2012) also showed that
DRG neurons that were maintained in NGF and exposed to a
pharmacological IAP antagonist showed no prodegenerative
effects, and therefore ruled out a role for IAPs in the regulation
of axonal caspases. Our genetic loss- and gain-of function
studies demonstrate that the actions of the IAPs are only mani-
fest after NGF withdrawal, when caspases are activated.
XIAP/ neurons maintained in NGF grow normally, and we
would predict that IAP antagonists would not drive degeneration
if sufficient trophic support were present.
Several previous studies that used immunocytochemical tech-
niques to detect cleaved caspases within degenerating axons760 Cell Reports 4, 751–763, August 29, 2013 ª2013 The Authorsproduced conflicting results. Some studies showed that the
cleaved caspase-3 epitope could be detected (Cowan and
Roskams, 2004; Cowan et al., 2001; Finn et al., 2000; Schoen-
mann et al., 2010), whereas others did not obtain that result
(Nikolaev et al., 2009). However, immunocytochemical analyses
consistently detect the presence of cleaved caspase-6 in degen-
erating sensory axons. Cleavage-specific caspase antibodies
detect the C-terminal epitope that is generated in the large
caspase subunit when the procaspase precursor is cleaved. For
caspase-3 and caspase-9, this same C-terminal epitope also
binds XIAP, and therefore cleavage-specific caspase antibodies
probably detect only the fraction of caspases that are not bound
to IAPs. Caspase-6 does not bind XIAP (or other IAPs), and this
may explain why cleaved caspase-6 is readily detected in degen-
erating axons. We found that XIAP/ axons show abundant
staining for the cleaved caspase-3 antigen when they are with-
drawn from NGF, consistent with the possibility that this
caspase-3 epitope is ‘‘unmasked.’’ An equally plausible explana-
tion is that the increased immunoreactivity reflects the increase
accumulation of cleaved caspase-3 in axons lacking XIAP.
Regardless, these data demonstrate that the presence of XIAP
is a complicating factor that significantly interferes with cleaved
caspase-3 immunoreactivity within degenerating sensory axons.
XIAP can block caspase-3, caspase-7, and caspase-9 within
in vitro settings and can thwart apoptosis when overexpressed
(Chai et al., 2001; Riedl et al., 2001; Salvesen and Duckett,
2002; Scott et al., 2005; Shiozaki et al., 2003; Sun et al., 2000;
Vaux and Silke, 2005). However, despite extensive investiga-
tions, the developmental or physiological circumstances in
which XIAP regulates apoptosis have not emerged. Therefore,
a vexing question facing the field is whether XIAP actually func-
tions as a caspase inhibitor under physiological conditions
in vivo. The physiological relevance of an IAP-caspase regulatory
circuit has already been clearly demonstrated in the fly nervous
system. In Drosophila, the XIAP homolog, DIAP1, plays a crucial
role in regulating caspases in the developing nervous system.
The DRONC caspase is constitutively active in fly neurons, and
therefore DIAP1 is required to restrain its activity during neuronal
growth. The massive reshaping of dendritic arbors that occurs
on ddAc sensory neurons during morphogenesis relies on disin-
hibition of this DIAP1-mediated caspase repression via proteo-
somal degradation of DIAP1, leading to local activation of
dendritic caspases. Because our data indicate that XIAP regu-
lates caspase activity in degenerating DRG sensory axons, and
that removal of XIAP via proteosomal degradation is a prerequi-
site for axonal degeneration, we conclude that the XIAP caspase
loop that regulates morphogenesis is phylogenetically con-
served from flies to mammals.
Neurons have a profound requirement for morphological re-
modeling, and roles for caspases in regulating local changes in
synapses and spines have recently emerged (Jiao and Li, 2011;
Li et al., 2010). Given their destructive potential, caspases that
contribute to sublethal morphogenic changes are certain to be
tightly controlled, and therefore XIAP is likely to play a key role
as a caspase regulator in a variety of nervous system settings.
Consistent with our results, Cusack et al. (2013) very recently
showed that DRG axons exposed to local NGF deprivation in mi-
crofluidic chambers undergo faster degeneration when they lack
XIAP. We suspect that DRG sensory axon degeneration most
likely represents an extreme endof a continuumofmorphological
changes that are controlled by caspase-dependent processes,
and we propose that a XIAP-caspase regulatory loop is neces-
sary to shape axonal and dendritic processes to changing phys-
iological needs.EXPERIMENTAL PROCEDURES
Mouse Strains
CD-1 and c57Bl/6 mice were purchased from Charles River Laboratories.
XIAP/ mice were previously described (Harlin et al., 2001).
CASP3/ mice were obtained from The Jackson Laboratory (strain
B6.129S1-Casp3tm1Flv/J). All animal procedures were approved by the
Canadian Council of Animal Care, and efforts were made to minimize the
number of manipulations and animals used.Antibodies and Reagents
Antibodies directed against histone H3 (1:2,000), neurofilament-M (1:20,000),
and b-III tubulin (Tuj-1, 1:60,000 for immunoblotting and 1:10,000 for immuno-
fluorescence) were obtained from Millipore. Antibodies directed against total
caspase-9 (1:500), total caspase-3 (1:2,000), total caspase-6 (1:200), cleaved
caspase-3 (1:250 for immunofluorescence), and cleaved caspase-6 (1:200)
were obtained from Cell Signaling Technology. Anti-actin (1:40,000) was
obtained from MP Biomedicals. Anti-RIAP3 (1:2,000), which recognizes
XIAP, was kindly provided by Robert G. Korneluk (University of Ottawa,
Ottawa, Canada). The pan-caspase inhibitor (zVAD-fmk, pan-casp-i) and
inhibitors of caspase-9 (z-LEHD-fmk, casp9-i), caspase- 6 (z-VEID-fmk,
casp6-i), and caspase-3 (z-DEVD-fmk, casp3-i) were obtained from R&D
Systems and were all used at a final concentration of 50 mM. The anti-NGF
neutralizing antibody was previously described (Acheson et al., 1991). NAD+
(Sigma Aldrich) was used at 5 mM. The calpain inhibitor ALLN (Calbiochem)
was used at 10 mM. Epoxomicin (Calbiochem) and bortezomib (Selleck)
were used at 1 mM and 10 mM, respectively.Lentiviral Infections
The human XIAP open reading frame was cloned into pDONR221. After
sequence fidelity was confirmed by sequencing, the open reading frame
construct was recombined into pLenti-OE-IRES-RFP and used to generate
lentiviral particles. Lentiviral particles derived from empty pDONR221 recom-bined into pLenti-OE-IRES-RFP were used as a control. Dissociated DRG
sensory neurons were transduced at a multiplicity of infection (moi) of 3.
DRG Culture and Treatments
Dissociated DRG neurons or DRG explants were prepared from E13.5 mouse
embryos (unless otherwise stated) and grown on cell culture filter inserts (1 mm
pore size; BD-Falcon) that, unless otherwise indicated, had been coated
sequentially with poly-D-lysine (1 mg/ml; Sigma-Aldrich), laminin (10 mg/ml;
Sigma-Aldrich), and collagen (0.1 mg/ml, PureCol; Advance BioMatrix). The
basal culture media consisted of Neurobasal (Invitrogen) supplemented with
2% B-27 (Invitrogen), 1% L-glutamine (Wisent), 1% penicillin/streptomycin
(Wisent), and 20 mM 5-fluoro-20-deoxyuridine (Sigma-Aldrich). For the first
2.5 days of axonal growth, the media in the bottom compartment were supple-
mented with 12.5 ng/ml NGF (Alomone). NGF deprivation was achieved by
changing themedia in all compartments to an NGF-free basal medium supple-
mented with anti-NGF antibody Rab1 (1 mg/ml). Axotomy was achieved in vitro
by scraping the top of the filters and putting them back into the incubator for
different time periods as indicated in the text. For dissociated DRG neurons,
ganglia were incubated in 1 ml of 0.25% trypsin for 10 min at 37C, supple-
mented with 10% fetal bovine serum, washed in Earle’s balanced salt solution,
and resuspended in basal media. DRGs were dissociated by passage through
a 1,000 ml tip, a 200 ml tip, and, finally, fire-polished Pasteur pipettes. For
biochemical analyses, 170,000 cells were seeded on six-well filter inserts;
for immunocytochemical analyses, 85,000 cells per filter were used.
Immunocytochemistry and Quantification of Axonal Degeneration
DRG cultures grown on filters were fixed with 4% paraformaldehyde for 10min
at room temperature and then blocked in blocking solution containing TBS-T,
5% skim milk, and 0.3% Triton X-100. The DRGs were then incubated over-
night at 4C with antibodies against b-III tubulin, diluted 1:10,000 in blocking
solution. Filter inserts were then incubated with Alexa488-conjugated goat
anti-mouse secondary antibodies (The Jackson Laboratory) for 1 hr at room
temperature. Before the last wash, the filters were also incubated with Hoescht
33258 (Invitrogen). The filters were removed from the insert, placed in fluores-
cent mounting medium (Dako), and mounted on Superfrost Plus slides (Fisher
Scientific). To examine the top and bottom surfaces of the filters in different
1.7 mm focal planes, imaging was performed on a confocal microscope
(LSM710; Zeiss). Axonal degeneration analysis was performed on a fluores-
cent inverted microscope equipped with LED illumination, and images were
captured and analyzed using Zen software (Zeiss). Axonal degeneration
quantification was performed essentially as described previously (Wakatsuki
et al., 2011). In brief, blinded b-III tubulin-stained filters were imagedwith a sys-
tematic random sampling approach, with one image per explant, 400 mmaway
from the center of the explant, and a total of 12–16 images per filter. Using the
NIH ImageJ software, the axonal area was determined by the total number of
detected pixels after binarization of the image using the threshold function. To
estimate the area occupied by the pixels from ‘‘normal’’ axons, degenerated
axons and debris were excluded by size (defined as small particles using the
ImageJ particle analyzer function). At least two filters were evaluated for
each condition and each experiment was repeated three times.
Axonal Preparations
For SDS-PAGE and western blot analysis, filters were washed twice with
ice-cold PBS. Cell bodies and axons from the top of the filter were scraped
into 50 ml PBS and lysed upon addition of 150 ml of 23 sample buffer. To obtain
pure axonal proteins, the top of the filter was then cleanedwith a cotton-tipped
applicator to ensure removal of cell-bodymaterial. The filter was then removed
from the insert, placed in 60 ml of 23 sample buffer, and boiled for 5 min.
Active Caspase Pull-Downs
After treatment and/or NGF deprivation for the times indicated, biotin-VAD-
fmk (bVAD; Santa Cruz Biotechnology) was added to the DRG cultures
(10 mM final concentration) and incubated for 1.5 hr to capture active
caspases. Cell culture inserts were then washed twice with ice-cold PBS.
Pure axonal samples were obtained as for the western blots, but lysed in
CHAPS lysis buffer (150 mM KCl, 50 mM HEPES, 5% glycerol, 0.5% CHAPS,
supplemented with a protease inhibitor tablet [Roche]). After lysis, membranesCell Reports 4, 751–763, August 29, 2013 ª2013 The Authors 761
from two filters were pooled. A 50 ml aliquot was set aside as an input control
and the remainder was incubated overnight with streptavidin-agarose beads
(Pierce) at 4C. The beads were washed extensively, and bound proteins
were eluted using sample buffer and analyzed by SDS-PAGE andwestern blot.
Skin Innervation Assessment
Skin innervation in E15.5 embryos was determined in cross-sections of the left
forelimb of nine embryos per genotype. Paraffin-embedded sections were
stained for b-III tubulin (Tuj-1, 1:5,000) and counterstained with DAPI. The
area of b-III tubulin-stained nerve fibers adjacent to the skin was evaluated
in 10 mm sections (20 per animal), each separated by 30 mm. The area of
b-III tubulin-stained nerve fibers is expressed per unit length of skin analyzed.
Assessment of the Number of Neurons in DRGs
Sensory neurons within DRGs were quantified in cross-sections at the level of
L1–L3 from embryos at E15.5. Tissue was embedded in paraffin and DRGs
were sectioned in situ (10 mm). Every third section was Nissl stained, and
neurons were counted and analyzed using the optical fractionator principle
(West et al., 1991). Systematic random sampling and the counting procedure
were performed using StereoInvestigator software (MicroBrightField) con-
nected to a Nikon Eclipse E800 microscope (Nikon Instruments) equipped
with an x/y/z-motorized stage and a color CCD camera (Microfire S99808;
Optronics). A total of eight DRGs were analyzed per genotype.
Statistical Analyses
All data are presented as mean ± SEM. Student’s t test (two-tailed) was used
for statistical tests.
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